Market Research Logo

Latin America Pharmaceuticals & Healthcare Q1 2018

Latin America Pharmaceuticals & Healthcare Q1 2018

BMI View: Macroeconomic and political instability throughout Latin America continue to pose downside risks for drugmaker revenues as access to pharmaceuticals and healthcare remains a concern. Despite this, the Latin America region's high demand for medicines and regulatory advancements will maintain drugmaker interest in the long term.


BMI Industry View
Latin America - Q1 2018
Table: Headline Pharmaceuticals & Healthcare Forecasts (Latin America (Region) 2015-2021)
SWOT
Latin America - Q1 2018
Industry Forecast
Pharmaceutical - Latin America - Q1 2018
Table: Regional Pharmaceuticals Sales, Historical Data & Forecasts (2013-2020)
Healthcare - Latin America - Q1 2018
Table: Regional Healthcare Sales, Historical Data & Forecasts (2013-2021)
Industry Risk/Reward Index
Americas Pharmaceuticals: Attractiveness To Drugmakers Masks Disparities Between Markets
Market Overview
Latin America - Q1 2018
Industry Trend And Developments
Regional Themes - Latin America - Q1 2018
Regional Overview
Regional Round-Up - Q118
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report